| Literature DB >> 35172869 |
Takumi Kawase1, Yosuke Takahashi2, Kenta Nishiya2, Noriaki Kishimoto2, Kokoro Yamane2, Yoshito Sakon2, Akimasa Morisaki2, Hiromichi Fujii2, Toshihiko Shibata2.
Abstract
OBJECTIVE: We investigated the effect of morphological diversity of the tricuspid valve with multiple posterior leaflets on the technical outcomes of tricuspid valve repair.Entities:
Keywords: Residual tricuspid regurgitation; Tricuspid valve; Two posterior leaflets
Mesh:
Year: 2022 PMID: 35172869 PMCID: PMC8848647 DOI: 10.1186/s13019-022-01762-5
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Flow diagram of patient selection. TR, tricuspid regurgitation
Fig. 2Operative findings of tricuspid valve with two posterior leaflets. A, anterior leaflet; P1 and P2, posterior leaflets; S, septal leaflet
Fig. 3The Tailor ring was sutured with the running suture technique. We avoided placing sutures around the septal leaflet’s annulus near the atrioventricular node. We confirmed significant coaptation of each valve by the saline injection test. The blue arrow indicates the shoulder point. A, anterior leaflet; P, posterior leaflet; S, septal leaflet
Fig. 4saline test after tricuspid valve repair. a Motion of septal leaflet was restricted and all leaflets could not have same coaptation height. b Only one posterior leaflet raised and other leaflets did not get adequate tension. There were gaps between a posterior leaflet and other leaflets. The yellow arrow indicated restricted septal leaflet. The red arrow indicated different height of posterior leaflet
Univariate and multivariate logistic regression analyses of the risk predictors of requiring additional procedures
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Model using echocardiographic data | ||||||
| Pre TR score | 2.3 | 1.3–4.1 | 0.0025 | 1.8 | 1.0–3.4 | 0.042 |
| PH (estimated RVSP of > 40 mmHg) | 2.6 | 1.2–6.0 | 0.021 | 1.9 | 0.79–4.6 | 0.15 |
| RA minimum (4-chamber view) | 1.0 | 0.99–1.1 | 0.14 | |||
| RA maximum (4-chamber view) | 1.0 | 0.99–1.0 | 0.28 | |||
| TRPG | 1.0 | 0.99–1.0 | 0.20 | |||
| LVDd (parasternal long-axis view) | 0.99 | 0.94–1.0 | 0.57 | |||
| LVDs (parasternal long-axis view) | 0.98 | 0.95–1.0 | 0.61 | |||
| TV diameter, mm/m2 | 0.97 | 0.89–1.1 | 0.44 | |||
| Model using clinical data | ||||||
| Valve with two posterior leaflets | 3.4 | 1.5–7.7 | 0.0036 | 2.6 | 1.1–6.1 | 0.033 |
| Male sex | 0.56 | 0.26–1.3 | 0.16 | |||
| Body surface area | 0.22 | 0.026–1.9 | 0.16 | |||
| Age | 1.0 | 0.96–1.1 | 0.75 | |||
| NYHA class ≥ II heart failure | 2.0 | 0.43–9.5 | 0.33 | |||
| Atrial fibrillation | 1.5 | 0.61–3.6 | 0.38 | |||
| Dyslipidemia | 2.0 | 0.82–4.6 | 0.13 | |||
| Ischemic heart disease | 2.3 | 0.93–5.7 | 0.078 | |||
OR odds ratio, CI confidence interval, Pre TR score preoperative tricuspid regurgitation score, PH pulmonary hypertension (estimated right ventricular systolic pressure > 40 mmHg), RVSP right ventricular systolic pressure, RA right atrium, TRPG transtricuspid pressure gradient, LVDd left ventricular diastolic dimension, LVDs left ventricular systolic dimension, TV tricuspid valve, NYHA New York Heart Association
Patient characteristics
| Group 1 | Group 2 | ||
|---|---|---|---|
| Preoperative characteristics | |||
| Male sex | 63 (58) | 14 (44) | 0.16 |
| Age, years | 71 ± 9.2 | 72 ± 10 | 0.51 |
| Body surface area, m2 | 1.6 ± 0.2 | 1.5 ± 0.18 | 0.22 |
| NYHA class ≥ II heart failure | 96 (88) | 30 (94) | 0.33 |
| Comorbidities | |||
| Atrial fibrillation | 73 (67) | 24 (75) | 0.38 |
| Systemic hypertension | 60 (55) | 21 (66) | 0.28 |
| Dyslipidemia | 23 (21) | 11 (34) | 0.13 |
| Diabetes mellitus | 16 (15) | 8 (25) | 0.19 |
| Cerebrovascular event | 21 (19) | 9 (28) | 0.29 |
| Ischemic heart disease | 18 (17) | 10 (31) | 0.077 |
| Chronic renal failure | 35 (32) | 14 (44) | 0.23 |
| COPD | 7 (6.4) | 2 (6.3) | 0.97 |
| Preoperative transthoracic echocardiographic data | |||
| RA minimum (4-chamber view), mm | 42 ± 11 | 45 ± 11 | 0.11 |
| RA maximum (4-chamber view), mm | 61 ± 13 | 65 ± 17 | 0.32 |
| LVEF, % | 55 ± 11 | 55 ± 14 | 0.36 |
| LVDd (parasternal long-axis view), mm | 51 ± 8.3 | 50 ± 9.2 | 0.44 |
| LVDs (parasternal long-axis view), mm | 34 ± 8.9 | 33 ± 9.5 | 0.6 |
| LA (parasternal long-axis view), mm | 52 ± 10 | 55 ± 13 | 0.58 |
| Pre TR score | 1.6 ± 0.7 | 2.1 ± 0.78 | 0.0046 |
| TRPG, mmHg | 32 ± 13 | 37 ± 16 | 0.13 |
| PH (estimated RVSP of > 40 mmHg) | 41 (38) | 19 (61) | 0.019 |
| TV diameter, mm/m2 | 24 ± 4.7 | 24 ± 4.3 | 0.69 |
Group 1: Patients who underwent ring annuloplasty alone
Group 2: Patients who required additional edge-to-edge repair with ring annuloplasty
Data are presented as n (%) or mean ± standard deviation
NYHA New York Heart Association, COPD chronic obstructive pulmonary disease, RA right atrium, LVEF left ventricular ejection fraction, LVDd left ventricular diastolic dimension, LVDs left ventricular systolic dimension, LA left atrium, Pre TR score preoperative tricuspid regurgitation score, TRPG transtricuspid pressure gradient, PH pulmonary hypertension (estimated right ventricular systolic (RSVP) pressure > 40 mmHg), TV tricuspid valve
Surgical data
| Group 1 | Group 2 | ||
|---|---|---|---|
| Morphological diversity | |||
| Valve with two posterior leaflets | 36 (33) | 20 (63) | 0.003 |
| Annuloplasty ring | |||
Carpentier-Edwards physio tricuspid Annuloplasty ring | 76 (70) | 26 (81) | 0.19 |
| Tailor flexible annuloplasty ring | 33 (30) | 6 (19) | |
| Ring size, mm | 29 ± 1.8 | 29 ± 1.7 | 0.19 |
| Concomitant procedures | |||
| AVR | 41 (38) | 5 (16) | 0.014 |
| MVP | 47 (43) | 15 (47) | 0.71 |
| MVR | 45 (41) | 16 (50) | 0.38 |
| AVR or MVP or MVR + maze procedure | 32 (29) | 6 (19) | 0.22 |
Group 1: Patients who underwent ring annuloplasty alone
Group 2: Patients who required additional edge-to-edge repair with ring annuloplasty
Data are presented as n (%) or mean ± standard deviation
AVR aortic valve replacement, MVP mitral valve repair, MVR mitral valve replacement
Postoperative transthoracic echocardiographic data
| Group 1 | Group 2 | ||
|---|---|---|---|
| RA minimum (4-chamber view), mm | 36 ± 6.1 | 36 ± 6.7 | 0.74 |
| RA maximum (4-chamber view), mm | 49 ± 8.5 | 47 ± 8.4 | 0.54 |
| LVEF, % | 52 ± 11 | 52 ± 12 | 0.81 |
| LVDd (parasternal long-axis view), mm | 48 ± 7.4 | 47 ± 7.7 | 0.32 |
| LVDs (parasternal long-axis view), mm | 32 ± 8.2 | 32 ± 7.9 | 0.72 |
| LA (parasternal long-axis view), mm | 46 ± 8.5 | 46 ± 8.4 | 0.46 |
| Post TR score | 0.7 ± 0.32 | 0.88 ± 0.49 | 0.043 |
| TRPG, mmHg | 19 ± 11 | 24 ± 14 | 0.05 |
| PH (estimated RVSP > 40 mmHg) | 0 (0) | 0 (0) |
Group 1: Patients who underwent ring annuloplasty alone
Group 2: Patients who required additional edge-to-edge repair with ring annuloplasty
Data are presented as n (%) or mean ± standard deviation
RA right atrium, LVEF left ventricular ejection fraction, LVDd left ventricular diastolic dimension, LVDs left ventricular systolic dimension LA left atrium, Pre TR score preoperative tricuspid regurgitation score, TRPG transtricuspid pressure gradient, PH pulmonary hypertension (estimated right ventricular systolic pressure (RSVP) > 40 mmHg)
Perioperative echocardiographic parameters for each number of valve leaflets
| One posterior valve leaflet | Two posterior valve leaflets | ||
|---|---|---|---|
| n = 85 | n = 56 | ||
| Preoperative data | |||
| RA minimum (4-chamber view), mm | 42 ± 11 | 43 ± 11 | 0.51 |
| RA maximum (4-chamber view), mm | 62 ± 13 | 63 ± 16 | 0.86 |
| LVEF, % | 53 ± 12 | 58 ± 9.2 | 0.014 |
| LVDd (parasternal long-axis view), mm | 51 ± 8.2 | 52 ± 8.9 | 0.34 |
| LVDs (parasternal long-axis view), mm | 33 ± 9.1 | 34 ± 8.9 | 0.76 |
| LA (parasternal long-axis view), mm | 52 ± 10 | 54 ± 12 | 0.25 |
| Pre TR score | 1.6 ± 0.67 | 1.9 ± 0.81 | 0.032 |
| TRPG, mmHg | 34 ± 15 | 32 ± 12 | 0.61 |
| PH (estimated RVSP > 40 mmHg) | 32 (38) | 28 (51) | 0.12 |
| TV diameter, mm/m2 | 24 ± 4.5 | 25 ± 4.7 | 0.42 |
| Postoperative data | |||
| RA minimum (4-chamber view), mm | 36 ± 6.3 | 35 ± 6.3 | 0.89 |
| RA maximum (4-chamber view), mm | 48 ± 8.0 | 49 ± 9.2 | 0.46 |
| LVEF, % | 52 ± 12 | 53 ± 10 | 0.82 |
| LVDd (parasternal long-axis view), mm | 48 ± 7.3 | 48 ± 7.8 | 0.96 |
| LVDs (parasternal long-axis view), mm | 32 ± 8.5 | 32 ± 7.6 | 0.97 |
| LA (parasternal long-axis view), mm | 45 ± 7.7 | 46 ± 9.5 | 0.77 |
| Post TR score | 0.76 ± 0.36 | 0.71 ± 0.4 | 0.58 |
| TRPG, mmHg | 21 ± 11 | 19 ± 12 | 0.41 |
Data are presented as n (%) or mean ± standard deviation
RA right atrium, LVEF left ventricular ejection fraction, LVDd left ventricular diastolic dimension, LVDs left ventricular systolic dimension, LA left atrium, Pre TR score preoperative tricuspid regurgitation score, Post TR score postoperative tricuspid regurgitation score, TRPG transtricuspid pressure gradient, PH pulmonary hypertension (estimated right ventricular systolic pressure (RSVP) > 40 mmHg), TV tricuspid valve